06.10.2021 22:10:00

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021

BOSTON, Oct. 6, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, November 9, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on November 9, 2021. 

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 3529538

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnofhttps://edge.media-server.com/mmc/p/apntfy73

A replay of the conference call and webcast will be available for one year beginning on November 9, 2021 at 11:00 a.m. EST using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.  

Investor Contact:                                   

Olga Guyette, Director-Investor Relations

(781) 356-9763

olga.guyette@haemonetics.com 


Media Contact:

Josh Gitelson, Director-Global Communications

(781) 356-9776

josh.gitelson@haemonetics.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2022-results-november-9-2021-301394550.html

SOURCE Haemonetics Corporation

Analysen zu Haemonetics Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Haemonetics Corp. 82,00 -0,61% Haemonetics Corp.